Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Prus

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|October 1, 2013
Effects of the neurotensin NTS₁ receptor agonist PD149163 on visual signal detection in ratsTodd M Hillhouse, Adam J Prus
Current Topics in Behavioral Neurosciences|June 29, 2016
The Discriminative Stimulus Properties of Drugs Used to Treat Depression and AnxietyAdam J Prus, Joseph H Porter
Psychopharmacology|September 17, 2008
Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studiesJoseph H Porter, Adam J Prus
Behavioural Pharmacology|August 24, 2010
Evaluation of the effects of α2 adrenoceptor antagonism with the D2 receptor antagonist raclopride on conditioned avoidance responding in ratsSarah M Jacobson, Adam J Prus
Behavioural Pharmacology|March 20, 2023
Lack of sex and estrous stage effects on compulsive behavior assessed using a schedule-induced polydipsia procedure in ratsMin Park-Oates, Adam J Prus
Pharmacology, Biochemistry, and Behavior|September 6, 2002
Reevaluation of PNU-99194A discriminative stimulus effects: potentiation by both a D2 antagonist and a D3/D2 agonistLisa E Baker, Adam J Prus
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 2011
The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in ratsElizabeth N Holly, Bree Ebrecht, Adam J Prus
Pharmacology, Biochemistry, and Behavior|January 31, 2004
Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanismsAdam J Prus, Lisa E Baker, Herbert Y Meltzer
Drug Development Research|July 25, 2017
The Neurotensin NTS<sub>1</sub> Receptor Agonist PD149163 Produces Antidepressant-Like Effects in the Forced Swim Test: Further Support for Neurotensin as a Novel Pharmacologic Strategy for Antidepressant DrugsLawrence M Carey, Remington J Rice, Adam J Prus
Current Topics in Behavioral Neurosciences|March 26, 2017
Translational Value of Drug Discrimination with Typical and Atypical Antipsychotic DrugsJoseph H Porter, Kevin A Webster, Adam J Prus
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|October 1, 2013
Effects of the neurotensin NTS₁ receptor agonist PD149163 on visual signal detection in ratsTodd M Hillhouse, Adam J Prus
Current Topics in Behavioral Neurosciences|June 29, 2016
The Discriminative Stimulus Properties of Drugs Used to Treat Depression and AnxietyAdam J Prus, Joseph H Porter
Psychopharmacology|September 17, 2008
Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studiesJoseph H Porter, Adam J Prus
Behavioural Pharmacology|August 24, 2010
Evaluation of the effects of α2 adrenoceptor antagonism with the D2 receptor antagonist raclopride on conditioned avoidance responding in ratsSarah M Jacobson, Adam J Prus
Behavioural Pharmacology|March 20, 2023
Lack of sex and estrous stage effects on compulsive behavior assessed using a schedule-induced polydipsia procedure in ratsMin Park-Oates, Adam J Prus
Pharmacology, Biochemistry, and Behavior|September 6, 2002
Reevaluation of PNU-99194A discriminative stimulus effects: potentiation by both a D2 antagonist and a D3/D2 agonistLisa E Baker, Adam J Prus
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 2011
The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in ratsElizabeth N Holly, Bree Ebrecht, Adam J Prus
Pharmacology, Biochemistry, and Behavior|January 31, 2004
Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanismsAdam J Prus, Lisa E Baker, Herbert Y Meltzer
Drug Development Research|July 25, 2017
The Neurotensin NTS<sub>1</sub> Receptor Agonist PD149163 Produces Antidepressant-Like Effects in the Forced Swim Test: Further Support for Neurotensin as a Novel Pharmacologic Strategy for Antidepressant DrugsLawrence M Carey, Remington J Rice, Adam J Prus
Current Topics in Behavioral Neurosciences|March 26, 2017
Translational Value of Drug Discrimination with Typical and Atypical Antipsychotic DrugsJoseph H Porter, Kevin A Webster, Adam J Prus
Pageof 4